WilliamRogerKellerMD

PubMed

• 4 citations
  Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.
  Michael J Spilka, William R Keller, Robert W Buchanan, James M Gold, James I Koenig, Gregory P Strauss> ;Acta Psychiatrica Scandinavica. 2022 May 1
• 15 citations
  Hyperdeactivation of the Default Mode Network in People With Schizophrenia When Focusing Attention in Space
  Britta Hahn, Alexander N. Harvey, James M. Gold, Bernard A. Fischer, William R. Keller, Thomas J. Ross, Elliot A. Stein> ;Schizophrenia Bulletin. 2016 Feb 28
• 15 citations
  Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia
  Robert W. Buchanan, Elaine Weiner, Deanna L. Kelly, James M. Gold, William R. Keller, James A. Waltz, Robert P. McMahon, David A. Gorelick> ;Schizophrenia Bulletin. 2015 Jul 1
• 68 citations
  Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.
  Deanna L. Kelly, Kelli M. Sullivan, Joseph Patrick McEvoy, Robert P. McMahon, Heidi J. Wehring, James M. Gold, Fang Liu, Dale Warfel, Gopal Vyas, Charles M. Richardson...> ;Journal of Clinical Psychopharmacology. 2015 Jun 1
• 41 citations
  Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.
  Gregory P. Strauss, William R. Keller, James I. Koenig, James M. Gold, Kathryn L. Ossenfort, Robert W. Buchanan> ;Schizophrenia Research. 2015 Mar 1
• 35 citations
  Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia
  Gregory P. Strauss, William R. Keller, James I. Koenig, Sara K. Sullivan, James M. Gold, Robert W. Buchanan> ;Schizophrenia Research. 2015 Mar 1
• 38 citations
  Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.
  Gregory P. Strauss, William R. Keller, James I. Koenig, James M. Gold, Katherine H. Frost, Robert W. Buchanan> ;Schizophrenia Research. 2015 Mar 1
• 8 citations
  Community adherence to schizophrenia treatment and safety monitoring guidelines.
  William R. Keller, Bernard A. Fischer, Robert J. McMahon, Walter Meyer, Melissa Blake, Robert W. Buchanan> ;The Journal of Nervous and Mental Disease. 2014 Jan 1
• 4 citations
  The risk of diabetes in deficit schizophrenia.
  William R. Keller, Carol Vidal, Eric S. Park, Gregory P. Strauss, Bernard A. Fischer> ;Clinical Schizophrenia & Related Psychoses. 2014 Jan 1
• 30 citations
  Treating symptomatic hyperprolactinemia in women with schizophrenia: Presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for th...
  Deanna L. Kelly, Heidi J. Wehring, Amber Earl, Kelli M. Sullivan, Faith Dickerson, Stephanie Feldman, Robert P. McMahon, Robert W. Buchanan, Dale Warfel, William R. Ke...> ;BMC Psychiatry. 2013 Aug 22
• 3 citations
  Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia
  William R. Keller, Bernard A. Fischer, Robert P. McMahon, Walter Meyer, Robert W. Buchanan> ;Schizophrenia Research. 2013 Jul 1
• 281 citations
  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.
  Gregory P. Strauss, William P. Horan, Brian Kirkpatrick, Bernard A. Fischer, William R. Keller, Pinar Miski, Robert W. Buchanan, Michael F. Green, William T. Carpenter> ;Journal of Psychiatric Research. 2013 Jun 1
• 77 citations
  A review of anti-inflammatory agents for symptoms of schizophrenia
  William R. Keller, Lionel M Kum, Heidi J. Wehring, Maju Mathew Koola, Robert W. Buchanan, Deanna L. Kelly> ;Journal of Psychopharmacology. 2013 Apr 1
• 149 citations
  Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.
  Gregory P. Strauss, William R. Keller, Robert W. Buchanan, James M. Gold, Bernard A. Fischer, Robert P. McMahon, Lauren T. Catalano, Adam J. Culbreth, William T. Carpe...> ;Schizophrenia Research. 2012 Dec 1
• 151 citations
  FACTOR STRUCTURE OF THE BRIEF NEGATIVE SYMPTOM SCALE
  Gregory P. Strauss, L. Elliot Hong, James M. Gold, Robert W. Buchanan, Robert P. McMahon, William R. Keller, Bernard A. Fischer, Lauren T. Catalano, Adam J. Culbreth, ...> ;Schizophrenia Research. 2012 Dec 1
• 47 citations
  Cortical structural abnormalities in deficit versus nondeficit schizophrenia
  Bernard A. Fischer, William R. Keller, Celso Arango, Godfrey D. Pearlson, Robert P. McMahon, Walter Meyer, Alan N. Francis, Brian Kirkpatrick, William T. Carpenter, Ro...> ;Schizophrenia Research. 2012 Apr 1
• 25 citations
  Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
  William R. Keller, Bernard A. Fischer, William T. Carpenter> ;CNS Neuroscience & Therapeutics. 2011 Apr 1
• 645 citations
  The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
  Robert W. Buchanan, Julie Kreyenbuhl, Deanna L. Kelly, Jason M. Noel, Douglas L. Boggs, Bernard A. Fischer, Seth Himelhoch, Beverly Fang, Eunice Peterson, Patrick R. A...> ;Schizophrenia Bulletin. 2010 Jan 1
• Join now to see all